| __timestamp | Regeneron Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2614539000 | 11056000000 |
| Thursday, January 1, 2015 | 3711019000 | 11356000000 |
| Friday, January 1, 2016 | 4560733000 | 11859000000 |
| Sunday, January 1, 2017 | 5475166000 | 10825000000 |
| Monday, January 1, 2018 | 6276700000 | 8296000000 |
| Tuesday, January 1, 2019 | 7081200000 | 7536000000 |
| Wednesday, January 1, 2020 | 7377200000 | 7725000000 |
| Friday, January 1, 2021 | 13634200000 | 7594000000 |
| Saturday, January 1, 2022 | 10612500000 | 6973000000 |
| Sunday, January 1, 2023 | 11301400000 | 7646000000 |
| Monday, January 1, 2024 | 12231500000 | 8064000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and innovation capabilities. Over the past decade, Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited have showcased contrasting trends in gross profit. From 2014 to 2023, Regeneron has seen a remarkable growth trajectory, with its gross profit surging by over 330%, peaking in 2021. This growth reflects Regeneron's strategic investments in research and development, leading to groundbreaking treatments.
Conversely, Teva's gross profit has experienced a decline of approximately 31% over the same period, highlighting challenges in its generic drug market and patent expirations. Despite a slight recovery in 2023, Teva's financial journey underscores the volatility and competitive pressures in the pharmaceutical sector. This comparison not only highlights the dynamic nature of the industry but also emphasizes the importance of innovation and strategic foresight.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Vertex Pharmaceuticals Incorporated vs Teva Pharmaceutical Industries Limited: A Gross Profit Performance Breakdown
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation
Gross Profit Analysis: Comparing Teva Pharmaceutical Industries Limited and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown
Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.